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Abstract. A method has been developed for immobilisation of antisera on fresh plastic 
tubes through an immunochemical bridge. This type of immobilisation has been shown to 
be more consistent than direct adsorption on plastic. Such immunochemically coated 
antisera on plastic tube has been used in the development of a noncentrifugation 
radioimmunoassay. This assay system has been found to be technically as sound as the 
conventional method. 
 
Keywords. Radioimmunoassay; polypeptide hormones; normal rabbit serum; bovine 
serum; antisera. 
 
 
Introduction 
 
Radioimmunoassay (RIA), a technique extensively used in all endocrinological 
investigations, utilizes the double antibody procedure for the separation of bound 
hormone. This method of separation is time consuming and requires additional reagents. 
Solid phase RIA's are developed in many laboratories, using antisera (a/s) immobilised on 
sephadex, cellulose etc. (Leif Wide, 1981; Chakrabarti et al., 1985). 
Attempts have been made to improve this system using antibody adsorbed on plastic tube, 
further eliminating a centrifugation step (Parsons, 1981; Murthy and Moudgal, 1986). In 
the present study, we have immobilised a/s on locally available plastic tube through an 
immunochemical bridge and report on the advantages of using such a system in RIA. 
 
 
Materials and methods 
 
Plastic tubes were purchased locally from Sarad Biochemicals, Bangalore. These 
were moulded of high density polyethylene All hormone a/s used in these 
investigations were raised by the conventional procedure in rabbit/monkey. 
Antisera for human chorionic gonadotropin (hCG) and ovine follicle stimulating 
hormone (oFSH) were raised in rabbit and monkey respectively. AntiIgG (to rabbit 
or monkey) was raised in goats. hCG was a gift sample from NIH, USA. All other 
reagents used were of analytical grade. Buffer used for RIA had 0·05 Μ phosphate 
and 0·025 Μ EDTA in physiological saline, pH 7·4 and had 1% bovine serum (BS)
(referred as RIA buffer). 
 
 
*To whom all correspondence should be addressed. 
Abbreviations used: RIA, Radioimmunoassay; a/s, antisera; hCG, human chorionic gonadotropin; 
oFSH, ovine follicle stimulating hormone; BS, bovine serum; PEG, polyethyleneglycol; hLH, human 
luteinizing hormone. 
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Preparation of immunochemical bridge 
 
Fresh plastic tubes were coated with 0·5 ml of normal rabbit serum (I) diluted in
water (1/1000 diluted), care being taken to see that the solution was pipetted to the
bottom of the tube preventing the formation of droplets of the coating solution on
the sides of the tube. Following overnight coating, free sites were saturated with 
in RIA buffer for 1 h. For extension of the bridge the tubes were washed, and 
0·6 ml antilgG (A) was added at high concentration (1/300 in RIA buffer, 4°C) to 
allow saturation of the IgG bound to the plastic surface with A. At this stage we 
have IgG-antiIgG (-IA) bridge. Further extension of the bridge, when required, was 
carried out as above using saturating concentration of IgG and antilgG to obtain 
required length of the immunochemical bridge. 
Preparation of the bridge starting from A was carried out in a similar fashion. In
all cases immunochemical bridges were made in such a way that the end point of 
the bridge contains antilgG. These were then stored at 4°C or – 20°C until use. 
Similarly -IA bridges for monkey system was prepared in an identical fashion using 
normal monkey serum and antilgG (monkey) in the goat. 
 
Adsorption of a/s on immunochemical bridge 
 
Plastic tubes with immunochemical bridge was washed twice with RIA buffer 
containing 1% BS, drained on a filter paper for 5–10 min. To these tubes 0·6 ml of 
a/s (1/10,000 to 1/300,000) diluted in RIA buffer was added. The primary re- 
quisite for coating a/s is that the antilgG used should be against the IgG of 
the species in which the a/s is raised. Binding of a/s was allowed to proceed at 
4°C overnight and the tubes were washed twice with 1 ml RIA buffer. These tubes 
were then stored at 4°C/–20oC until used. 
 
Quantitation of adsorption of a/s 
 
Antisera at 1/100,000 was added to immunochemically coated tube (600 µl). After 
the adsorption the quantity of a/s remaining in the supernatant was measured with  
respect to control a/s, by its binding to 125I-hCG. The quantity of a/s adsorbed was 
then quantitated by the decrease in the binding of 125I-hCG. 
 
Direct adsorption of a/s on plastic 
 
The adsorption was carried out as described by Murthy and Moudgal (1986).
Briefly a/s at 1/10,000 dilution in distilled water was added (0·5 ml) to fresh plastic
tubes and allowed to adsorb at room temperature overnight. The a/s was discarded, 
and RIA buffer (0·6 ml) was added to these tubes to saturate the unsaturated 
binding sites. After 1 h the solution was discarded and tubes were stored at 4°C 
until further use. 
 
Binding of  125I-hormones to a/s coated tubes 
 
Antisera coated tubes were washed with RIA buffer, drained and to each tube 
 
Noncentrifugation radioimmunoassay 11 
 
0·6 ml of RIA buffer containing 50,000–100,000 cpm of 125I-hormone was added. 
The tubes were left on the bench overnight. Next morning the solution was poured 
out, tube washed once with RIA buffer and counted in a LKB gamma counter. 
 
Competitive binding assay with a/s coated tubes 
 
Antisera coated tubes were incubated with sample or hormone (varying amount in 
each tube) and 125I-hormone, all in RIA buffer in a total volume of 0·6 ml as 
already described (Murthy and Moudgal, 1986). Incubation was carried out on the 
bench for 20 h at room temperature, the tubes drained and washed once with 1 ml 
RIA buffer and counted. Conventional competitive binding assays were carried out  
by the standard procedure using double antibody-polyethyleneglycol (PEG) for 
separation of the bound hormone from the free hormone (Murthy and Moudgal, 
1987). 
Binding assays were analysed by Scatchard method (Scatchard, 1949). In each 
analysis correction for the damage of hormone during iodination was applied as 
described (Murthy and Freisen, 1985). 
 
Results 
 
Figure 1 shows the optimisation of the antilgG dilution to be used for the 
 
Figure 1. Titration of antilgG concentration required for saturation of IgG adsorbed on 
the plastic tube. Plastic tubes were first coated with NRS at 1/1000 dilution in water 
followed by saturation with antilgG at varying concentration. 
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preparation of the immunochemical bridge. It is seen that a dilution of 1/2000 is 
required to saturate all the IgG bound to the plastic tube. If the saturation needs to 
be done in shorter time a higher antilgG concentration (1/100) can be used 
reducing this period to 2–3 h. 
Figure 2 shows the time course of adsorption of a/s by the immunochemical
bridge by (i) 125I-hCG binding to the a/s adsorbed tube (curve a) and (ii) by 
 
Figure 2. Adsorption of a/s by-IA tubes with time. Curve (a), 125I-hCG bound to a/s
coated plastic tube; curve (b), per cent a/s adsorbed by -IA plastic tube. The binding was 
measured-as described under methods. 
 
decrease in the binding of 125I-hCG to the unadsorbed a/s from the tube in  
conventional binding assay (curve b). It is seen clearly that increased a/s adsorption  
as measured by both methods are nearly parallel indicating that binding of a/s on  
the solid phase through immunochemical bridge results in uniform retention of  
activity of the a/s. 
Table 1 shows a comparison of the consistency of binding of 125I-hormone to a/s
adsorbed to plastic tube directly or through -IA, -IAIA and -ΑΙΑ bridges, along 
with the specific binding obtained with conventional method (double antibody- 
PEG). The consistency of binding is about ± 4% for direct binding. In contrast the 
binding to tubes immunochemically coated with a/s was ±2%. This consistency is 
almost the same as that obtained for conventional liquid phase assay. Thus it is 
clear that the. binding of 125I-hormone to immobilised a/s on plastic through 
immunochemical bridge is highly consistent. It is also seen from the table that this 
consistency is not only seen for one hormone, but is true for hCG, oFSH and 
human luteinizing hormone (hLH). 
Table 2 shows the stability of the a/s coated tubes (thorough -IA and –IAIA
bridge) for storage. It is seen clearly that the binding of 125I-hormone is not 
significantly decreased on storage as the per cent bound is (last column) nearly same 
for 45 days (for hCG a/s) and 80 days (for oFSH a/s). Small differences seen in per 
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Table 1.  Comparison of  125I-hormone binding to immobilized a/s 
through immunochemical bridges* 
 
*Binding of hLH was done for hCG a/s adsorbed on the plastic tube. 
For hCG and oFSH, plastic tubes coated with corresponding a/s was 
used. 
 
Table 2 Stability of a/s coated tube.
* Immunologically active 
 
cent bound is not significant considering that the 125I-hormones used are different 
for each experiment. On storage the consistency of binding (SD) do not change, 
indicating that the a/s adsorbed on the plastic through immunochemical bridge is 
infact stable for atleast 90–100 days. 
Comparison of the assay using immobilised a/s and normal a/s is shown in figure
3. With regard to sensitivity, binding and consistency the assays are comparable. In 
the inset of the figure 3 is shown the Scatchard plot of the two assays. The Ka and 
capacity are infact measurable. The apparent Ka in the solid phase appears to be 
rather low, compared to that in the liquid phase. 
Competitive binding of 125I-oFSH to immunochemically immobilised a/s on 
plastic tube (curve b) and normal a/s (curve a) is shown in figure 4. The profiles are 
similar and the duplicates are comparable to that of the conventional double 
antibody assay. Table 3 shows the consistency and parallelism obtained for the 
measurement of a control sample of oFSH in 5 determinations using the a/s coated 
plastic tube. Figure 5 provides a consolidated displacement profiles of all these 
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Figure 3. Displacement profile in RIA using immobilised antibody on plastic tube (curve  
a) and conventional method (curve b) for hCG. Tubes were coated with 1/200,000 a/s 
(0·6 ml) on -IA bridge. Liquid phase assay was done using 100 µl of 1/100,000 a/s in a total 
volume of 0·6 ml. 125I-hCG added was 60,000 cpm in both cases. Insets A and Β show the
Scatchard plots for curves (a) and (b) respectively. 
 
 
Figure 4.  Displacement data of RIA using conventional method (curve a) and
noncentrifugation method using immobilised a/s on plastic tube (curve b) for oFSH.
Plastic tubes were coated with 1/100,000 a/s (0·6 ml) on -IAIA bridge. Liquid phase assay 
was done using 1/25,000 (100 µl) a/s. 125I-oFSH added was 50,000 cpm per tube (-IAIA 
bridge). 
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Table 3. Analysis of tube RIA using immunochemically coated a/s on 
plastic tubes through -IAIA bridge. 
 
 
Figure 5.  Displacement profile in oFSH RIA's using a/s (for oFSH) immobilised on
plastic tube through -IAIA bridge. The -IAIA bridges were coated with 1/100,000 a/s
(0·6 ml). A total of 5 assays were done over a period of 2 weeks using plastic tubes coated
with the a/s. The bars show the SD of specific binding at each concentration of the
hormone. 
 
 
assays. They are superimposable indicating good reproducibility of the assay.
Figure 6 presents displacement analysis in hLH assay system using -IA coated a/s. 
Inset in the figure shows the B/Bo vs concentration plot of 4 such assays (curve a). 
These results clearly indicate that the solid phase assay is quite consistent and 
reproducible and is independent of the nature of the bridge (-IA or -IAIA) used for 
the adsorption of the a/s. Displacement of 125I-hLH by a human serum is also 
shown in the inset (curve b), which is parallel to normal displacement. 
Tables 4 and 5 show the effect of normal serum (human, sheep and rabbit) and 
recovery of the exogeneously added hCG from serum samples. The recovery is 
quantitative with negligible interference from serum. Figure 7 (curves a, b and c) 
shows the displacement profile with immobilised a/s (on plastic through 
immunochemical bridge) in the absence of serum (curve a), and presence of 100 µl of 
human serum (curves b and c). Inset in the figure shows the plot of B/Bo vs 
hormone concentration for ally the 3 cases in the figure. Absolute overlapping clearly 
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Figure 6. Representative displacement profile in solid phase RIA for hLH using 
immobilised a/s on -IA bridge· Inset shows the B/Bo vs concentration plot for 4 such assays 
(curve a). Displacement of 125I-hLH in one of the assay by different volumes of a human 
serum sample obtained from WHO for a qc program (curve b). Vertical bars represents the 
± SD at each concentration of the hormone used for displacement. 
 
 
Table 4. Recovery of hormone (hCG) by RIA in the presence of normal sheep and 
rabbit serum (type of bridge used is -IA). 
 *Specific binding in the presence of sheep and rabbit serum with respect to the 
buffer, sp. binding was 94 and 97% respectively. 
 
demonstrates that the binding characteristics of the 125I-hCG to the adsorbed a/s is 
same in the absence and presence of serum samples. Table 6 shows the recovery of 
the exogeneously added hLH to human serum samples described under figure 7. 
Recovery is quantitative from serum samples carrying basal hLH also. Curve d in
figure 7 and curve b in figure 6 show the displacement pattern by varying volumes
of human serum samples and is parallel to normal displacement profile.
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Table 5. Recovery of hormone (hCG) from human 
serum samples*. 
 
*Random serum samples from different individuals. 
Specific binding of 125I-hCG in the presence of these 
human serum samples was found to be 99·5 ± 5% 
(100 µl serum, n=18) compared to the binding in the 
buffer (type of the bridge -IAIA). 
 
 
Figure 7. Displacement profile and recovery of hLH in solid phase RIA. The type of the 
bridge used was -IA. Curve (a), Normal displacement profiles; curves (b) and (c), 
displacement profiles in hLH RIA in the presence of 100 µl of two serum samples 1 and 2 
with basal hLH levels of 11 and 19 ng/ml respectively; curve (d), displacement of 125I-hLH 
by a human serum sample. Inset represents B/Bo*100 vs hLH concentration for curves (a), 
(b) and (c) respectively. The nature of the samples used is explained under table 6. 
 
 
Table 7 shows a comparison of quantitative aspects of a/s adsorbed on the plastic 
tube either by direct coating or through -IA bridge. The results clearly demonstrate 
that the adsorption of a/s in both the direct method and through the bridge per 
tube corresponds to about 150–200 µl (1/100,000 dilution) and this gives about 
20–25% greater binding than 100 µl of a/s (1/100,000 dilution). It is to be noted that 
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Table 6. Recovery of hormone (hLH) from human serum samples 
containing basal hLH*. 
 
*Both the serum samples used were from two female volunteers during 
10–14 days of the cycle. hCG a/s was used for the measurement of hLH 
using 125I-hLH as tracer and hLH for displacement (type of the bridge 
-IA). 
 
 
Table 7. Efficiency of a/s adsorption and comparison of 125I-hCG binding 
between adsorbed and normal a/s. 
 
aThis was calculated by the binding of 125I-hCG to the a/s left after adsorption. 
bThis also represents the volume of the a/s that is used for binding the 125I-hCG. 
cData for -IA and normal binding are taken from figure 3. 
dThis represents the binding that is obtained in the conventional binding done 
under same conditions· 
 
 
the adsorption of a/s by immunochemical bridge is near quantitative (60%) com- 
pared to the direct method which is less than 5%. 
 
 
Discussion 
 
The data presented clearly demonstrates that the adsorption of antibody through 
immunochemical bridge is satisfactory. It is seen from table 1 that consistency of  
binding to immunochemically adsorbed a/s is comparable to the binding observed  
in the liquid phase (conventional method). The consistency is far superior to that 
observed with the tubes coated with a/s directly. This observation is true for 
several hormones as shown in the table (hCG, oFSH and hLH). 
Immunochemically coated tubes are stable at 4°C for atleast 3 months, and
probably longer. This observation makes it viable to have a large number of tubes
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coated and stored at 4°C and use it as required. Making -IA or -IΑΙΑ bridge is a 
batch operation and as many as 1000–2000 tubes can be coated within 4 h with 
minimal fatigue. In the whole operation the only place where care needs to be 
exercised is in the first step (addition of normal rabbit serum). Subsequent steps are 
much like in enzyme-linked immunosorbent assay operations. 
Competitive binding analysis of direct a/s, and immunochemically adsorbed a/s 
on plastic tubes (table 2, figures 1 and 3) clearly show that duplicates in the 
conventional method and immobilised a/s method are comparable. The sensitivity 
of the assay using immunochemically coated tubes is of the same order as that of 
the conventional method. 
Consistency of the tube assay is definitely acceptable (figures 5 and 6) where 
consolidated displacement analysis of 5 assays are presented. The mean values 
obtained within an assay and between assays is within limits as in the conventional 
method (222+10 ng/ml, and 217+15 ng/ml), Scatchard plot of displacement 
analysis by homogeneous (conventional) and plastic tube methods show that the 
plots are linear in both cases. However Ka in the plastic tube method appears to be 
little on the lower side. Apparent capacity for the plastic tube is about 4 ng/tube. 
Considering that the reaction between the hormone and antibody in the plastic 
tube assay is nonhomogeneous, neither the capacity nor the affinity can be taken 
seriously. 
Interference from serum on specific binding to the coated a/s is insignificant. 
Recovery of the hormones added exogeneously to serum sample (human, sheep and 
rabbit, 100 µl) are quantitative clearly demonstrating that this method has a 
potential application in measuring hormones in serum samples. The fact that 
parallel displacement is seen for human serum sample in hLH measurement justifies 
the above conclusion (figure 7). In addition the binding characteristic of the 
125I-hLH to a/s coated tube is not affected by the presence of serum is clear from the  
inset in figure 3. The above conclusion is also drawn from the data shown in table 4 
for sheep and rabbit serum. Thus serum interference in the assay is ruled out. 
The above assay system is economical in terms of double antibody as well as 
primary a/s. The quantity of the double antibody required in this system per tube is 
100-fold less than the requirement in the liquid phase assay. It is also very 
economical in terms of the a/s required. For example in hCG a/s the requirement in 
the liquid phase would be 100 µl of 1/100,000 dilution. The volume of a/s adsorbed 
immunochemically on the plastic tube is hardly equivalent to 150–200 µl (1/100,000; 
dilution-60% of 600 µl of 1/200,000 a/s is adsorbed), this giving about 20% more 
binding than in the liquid phase. In the direct method of coating 600 µl of 1/20,000 
dilution of a/s is required which is about 30 times more, only about 5% or less 
being adsorbed, the remaining 95% becoming nonfunctional because of inactivation 
of a/s at such high dilutions in the absence of proteins. Such inactivation of a/s for 
both hCG as well as oFSH has been observed in our laboratory. Thus 
immunochemical method of adsorption of the a/s is extremely economical in terms 
of primary a/s in comparison to any other method of immobilisation known so far. 
The type of immunochemical bridge does not appear to have any preference in
RIA. The recovery of the hormone in -IA, ΑΙΑ and -IAIA bridges are all excellent, 
stability and consistency comparable and interference from serum sample 
insignificant. Hence technically there is little to choose among the 3. -IA bridge 
would require least manipulations and hence probably the most useful practically 
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-IA bridge to rabbit and monkey systems have worked well (for hCG and oFSH 
respectively) and there is no reason to believe that other systems may present 
problems. Manipulation wise this method is also very simple. Once the coated tubes 
are available the operations are minimal involving addition of bluffer, standard or 
sample and 125I-hormone. There is no requirement of the centrifugation nor the 
manipulations for the separation of the bound hormone from the free hormone. 
Thus a/s coated plastic tubes through immunochemical bridge has all the 
technical advantages of double antibody method. In addition it has the following 
other advantages: (i) requires 100-fold less of double antibody, (ii) does not require 
centrifugation, (iii) has much less experimental manipulation and (iv) extremely 
economical on the a/s, almost nearly the same as in the conventional liquid phase 
assay. Added to these practical advantages are that the a/s coated tubes are stable 
for atleast 90 days. Hence a mass scale preparation of a/s coated tubes can be 
undertaken. 
On the basis of these data we believe that this method of RIA is an alternative to 
expensive double antibody method. The method retains all the technical excellence 
of the conventional method and possess other practical advantages of economy and
ease of operation. 
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